AAAAAA

   
Results: 1-25 | 26-50 | 51-75 | 76-100 | >>
Results: 1-25/102
-455G A POLYMORPHISM OF THE BETA-FIBRINOGEN GENE IS ASSOCIATED WITH THE PROGRESSION OF CORONARY ATHEROSCLEROSIS IN SYMPTOMATIC MEN - PROPOSED ROLE FOR AN ACUTE-PHASE REACTION PATTERN OF FIBRINOGEN/
Authors: DEMAAT MPM KASTELEIN JJP JUKEMA JW ZWINDERMAN AH JANSEN H GROENEMEIER B BRUSCHKE AVG KLUFT C
Citation: Mpm. Demaat et al., -455G A POLYMORPHISM OF THE BETA-FIBRINOGEN GENE IS ASSOCIATED WITH THE PROGRESSION OF CORONARY ATHEROSCLEROSIS IN SYMPTOMATIC MEN - PROPOSED ROLE FOR AN ACUTE-PHASE REACTION PATTERN OF FIBRINOGEN/, Arteriosclerosis, thrombosis, and vascular biology, 18(2), 1998, pp. 265-271
EFFICACY AND 6-MONTH SAFETY OF SIMVASTATIN 80 MG DAY - RESULTS FROM THE WORLDWIDE SIMVASTATIN EXPANDED DOSE PROGRAM (WSEDP)/
Authors: OSE L KASTELEIN JJP SCOTT R STEIN EA CAMPODONICO S ESCOBAR ID TATE AC CORSETTI L SHAHANE A MITCHEL YB MERCURI M
Citation: L. Ose et al., EFFICACY AND 6-MONTH SAFETY OF SIMVASTATIN 80 MG DAY - RESULTS FROM THE WORLDWIDE SIMVASTATIN EXPANDED DOSE PROGRAM (WSEDP)/, NMCD. Nutrition Metabolism and Cardiovascular Diseases, 8(3), 1998, pp. 135-143
FAMILIAR HYPERCHOLESTEROLEMIA - THE LIMITED PREDICTIVE VALUE OF PLASMA LDL-CHOLESTEROL
Authors: UMANSECKENHAUSEN MAW DEFESCHE JC KASTELEIN JJP
Citation: Maw. Umanseckenhausen et al., FAMILIAR HYPERCHOLESTEROLEMIA - THE LIMITED PREDICTIVE VALUE OF PLASMA LDL-CHOLESTEROL, Journal of the American College of Cardiology, 31(2), 1998, pp. 148-149
A NATIONAL SCREENING-PROGRAM FOR THE IDENTIFICATION OF PERSONS WITH FAMILIAL HYPERCHOLESTEROLEMIA IN THE NETHERLANDS
Authors: UMANSECKENHAUSEN MAW DEFESCHE JC CLINE F KASTELEIN JJP
Citation: Maw. Umanseckenhausen et al., A NATIONAL SCREENING-PROGRAM FOR THE IDENTIFICATION OF PERSONS WITH FAMILIAL HYPERCHOLESTEROLEMIA IN THE NETHERLANDS, Journal of the American College of Cardiology, 31(2), 1998, pp. 303-303
ILE(225)THR LOOP MUTATION IN THE LIPOPROTEIN-LIPASE (LPL) GENE IS A DE-NOVO EVENT
Authors: HENDERSON HE BIJVOET SM MANNENS MAMM BRUIN T ERKELENS DW HAYDEN MR KASTELEIN JJP
Citation: He. Henderson et al., ILE(225)THR LOOP MUTATION IN THE LIPOPROTEIN-LIPASE (LPL) GENE IS A DE-NOVO EVENT, American journal of medical genetics, 78(4), 1998, pp. 313-316
MOLECULAR EPIDEMIOLOGY OF FAMILIAL HYPERCHOLESTEROLEMIA
Authors: DEFESCHE JC KASTELEIN JJP
Citation: Jc. Defesche et Jjp. Kastelein, MOLECULAR EPIDEMIOLOGY OF FAMILIAL HYPERCHOLESTEROLEMIA, Lancet, 352(9141), 1998, pp. 1643-1644
THE FUNCTIONAL AND CLINICAL-SIGNIFICANCE OF THE MET-]THR SUBSTITUTIONIN KRINGLE-IV TYPE-10 OF APOLIPOPROTEIN(A)
Authors: PRINS J VANDERHOEK YY BIESHEUVEL TH LEUS FR VANRIJN HJM KASTELEIN JJP
Citation: J. Prins et al., THE FUNCTIONAL AND CLINICAL-SIGNIFICANCE OF THE MET-]THR SUBSTITUTIONIN KRINGLE-IV TYPE-10 OF APOLIPOPROTEIN(A), Thrombosis research, 90(3), 1998, pp. 125-130
POLYMORPHISM OF THE CHOLESTERYL ESTER TRANSFER PROTEIN GENE - REPLY
Authors: KUIVENHOVEN JA KASTELEIN JJP
Citation: Ja. Kuivenhoven et Jjp. Kastelein, POLYMORPHISM OF THE CHOLESTERYL ESTER TRANSFER PROTEIN GENE - REPLY, The New England journal of medicine, 338(22), 1998, pp. 1625-1626
THE ROLE OF A COMMON VARIANT OF THE CHOLESTEROL ESTER TRANSFER PROTEIN GENE IN THE PROGRESSION OF CORONARY ATHEROSCLEROSIS
Authors: KUIVENHOVEN JA JUKEMA JW ZWINDERMAN AH DEKNIJFF P MCPHERSON R BRUSCHKE VG LIE KI KASTELEIN JJP
Citation: Ja. Kuivenhoven et al., THE ROLE OF A COMMON VARIANT OF THE CHOLESTEROL ESTER TRANSFER PROTEIN GENE IN THE PROGRESSION OF CORONARY ATHEROSCLEROSIS, The New England journal of medicine, 338(2), 1998, pp. 86-93
PLASMA AND FIBROBLASTS OF TANGIER-DISEASE PATIENTS ARE DISTURBED IN TRANSFERRING PHOSPHOLIPIDS ONTO APOLIPOPROTEIN-A-I
Authors: VONECKARDSTEIN A CHIRAZI A SCHULERLUTTMANN S WALTER M KASTELEIN JJP GEISEL J REAL JT MICCOLI R NOSEDA G HOBBEL G ASSMANN G
Citation: A. Voneckardstein et al., PLASMA AND FIBROBLASTS OF TANGIER-DISEASE PATIENTS ARE DISTURBED IN TRANSFERRING PHOSPHOLIPIDS ONTO APOLIPOPROTEIN-A-I, Journal of lipid research, 39(5), 1998, pp. 987-998
INCREASED OXIDIZABILITY OF LOW-DENSITY LIPOPROTEINS IN HYPOTHYROIDISM
Authors: DIEKMANN T DEMACKER PNM KASTELEIN JJP STALENHOEF AFH WIERSINGA WM
Citation: T. Diekmann et al., INCREASED OXIDIZABILITY OF LOW-DENSITY LIPOPROTEINS IN HYPOTHYROIDISM, The Journal of clinical endocrinology and metabolism, 83(5), 1998, pp. 1752-1755
LIPID-FREE APOLIPOPROTEIN (APO) A-I IS CONVERTED INTO ALPHA-MIGRATINGHIGH-DENSITY-LIPOPROTEINS BY LIPOPROTEIN-DEPLETED PLASMA OF NORMOLIPIDEMIC DONORS AND APO A-I-DEFICIENT PATIENTS BUT NOT OF TANGIER-DISEASEPATIENTS
Authors: VONECKARDSTEIN A HUANG YD KASTELEIN JJP GEISEL J REAL JT KUIVENHOVEN JA MICCOLI R NOSEDA G ASSMANN G
Citation: A. Voneckardstein et al., LIPID-FREE APOLIPOPROTEIN (APO) A-I IS CONVERTED INTO ALPHA-MIGRATINGHIGH-DENSITY-LIPOPROTEINS BY LIPOPROTEIN-DEPLETED PLASMA OF NORMOLIPIDEMIC DONORS AND APO A-I-DEFICIENT PATIENTS BUT NOT OF TANGIER-DISEASEPATIENTS, Atherosclerosis, 138(1), 1998, pp. 25-34
GENDER-RELATED ASSOCIATION BETWEEN THE -93T-]G D9N HAPLOTYPE OF THE LIPOPROTEIN-LIPASE GENE AND ELEVATED LIPID-LEVELS IN FAMILIAL COMBINED HYPERLIPIDEMIA/
Authors: HOFFER MJV BREDIE SJH SNIEDER H REYMER PWA DEMACKER PNM HAVEKES LM BOOMSMA DI STALENHOEF AFH FRANTS RR KASTELEIN JJP
Citation: Mjv. Hoffer et al., GENDER-RELATED ASSOCIATION BETWEEN THE -93T-]G D9N HAPLOTYPE OF THE LIPOPROTEIN-LIPASE GENE AND ELEVATED LIPID-LEVELS IN FAMILIAL COMBINED HYPERLIPIDEMIA/, Atherosclerosis, 138(1), 1998, pp. 91-99
LIPASE GENE-MUTATIONS AND FAMILIAL COMBINED HYPERLIPIDEMIA PHENOTYPES
Authors: STALENHOEF AFH BREDIE SJH KASTELEIN JJP FRANTS RR HOFFER MJV
Citation: Afh. Stalenhoef et al., LIPASE GENE-MUTATIONS AND FAMILIAL COMBINED HYPERLIPIDEMIA PHENOTYPES, Atherosclerosis (Amsterdam), 138, 1998, pp. 13-13
THE ASN9 VARIANT OF LIPOPROTEIN-LIPASE IS ASSOCIATED WITH THE -93G PROMOTER MUTATION AND AN INCREASED RISK OF CORONARY-ARTERY DISEASE
Authors: KASTELEIN JJP GROENEMEYER BD HALLMAN DM HENDERSON H REYMER PWA GAGNE SE JANSEN H SEIDELL JC KROMHOUT D JUKEMA JW BRUSCHKE AVG BOERWINKLE E HAYDEN MR
Citation: Jjp. Kastelein et al., THE ASN9 VARIANT OF LIPOPROTEIN-LIPASE IS ASSOCIATED WITH THE -93G PROMOTER MUTATION AND AN INCREASED RISK OF CORONARY-ARTERY DISEASE, Clinical genetics, 53(1), 1998, pp. 27-33
NIFEDIPINE IMPROVES NO MEDIATED VASODILATION IN HYPERCHOLESTEROLEMIA,INDEPENDENT OF AN EFFECT ON BLOOD-PRESSURE OR PLASMA-LIPIDS
Authors: VERHAAR MC HONING MLH VANDAM T ZWART M KOOMANS HA KASTELEIN JJP RABELINK TJ
Citation: Mc. Verhaar et al., NIFEDIPINE IMPROVES NO MEDIATED VASODILATION IN HYPERCHOLESTEROLEMIA,INDEPENDENT OF AN EFFECT ON BLOOD-PRESSURE OR PLASMA-LIPIDS, Circulation, 98(17), 1998, pp. 1258-1258
COMMON VARIANTS OF LIPOPROTEIN-LIPASE (LPL) STRONGLY INFLUENCE LEVELSOF LIPIDS AND LIPOPROTEINS AND CORONARY-ARTERY DISEASE (CAD) IN PATIENTS WITH FAMILIAL HYPERCHOLESTEROLEMIA (FH)
Authors: KASTELEIN JJP WITTEKOEK ME LOUBSER O CLEE SM COLLINS J MOLL E PIMSTONE SN HAYDEN MR
Citation: Jjp. Kastelein et al., COMMON VARIANTS OF LIPOPROTEIN-LIPASE (LPL) STRONGLY INFLUENCE LEVELSOF LIPIDS AND LIPOPROTEINS AND CORONARY-ARTERY DISEASE (CAD) IN PATIENTS WITH FAMILIAL HYPERCHOLESTEROLEMIA (FH), Circulation, 98(17), 1998, pp. 3873-3873
LIPOPROTEIN-LIPASE (LPL) ACTIVITY IS DECREASED IN CAD PATIENTS AND INVERSELY CORRELATED WITH SEVERITY OF ANGINA-PECTORIS AND SILENT-MYOCARDIAL-ISCHEMIA
Authors: KASTELEIN JJP JUKEMA JW VANBOVEN AJ JANSEN H ZWINDERMAN AH RABELINK TJ PETERS RJG LIE KI BRUSCHKE AVG HAYDEN MR
Citation: Jjp. Kastelein et al., LIPOPROTEIN-LIPASE (LPL) ACTIVITY IS DECREASED IN CAD PATIENTS AND INVERSELY CORRELATED WITH SEVERITY OF ANGINA-PECTORIS AND SILENT-MYOCARDIAL-ISCHEMIA, Circulation, 98(17), 1998, pp. 3876-3876
A COMMON MUTATION IN THE LIPOPROTEIN-LIPASE GENE (N291S) ALTERS THE LIPOPROTEIN PHENOTYPE AND RISK FOR CARDIOVASCULAR-DISEASE IN PATIENTS WITH FAMILIAL HYPERCHOLESTEROLEMIA
Authors: WITTEKOEK ME PIMSTONE SN REYMER PWA FEUTH L BOTMA GJ DEFESCHE JC PRINS M HAYDEN MR KASTELEIN JJP
Citation: Me. Wittekoek et al., A COMMON MUTATION IN THE LIPOPROTEIN-LIPASE GENE (N291S) ALTERS THE LIPOPROTEIN PHENOTYPE AND RISK FOR CARDIOVASCULAR-DISEASE IN PATIENTS WITH FAMILIAL HYPERCHOLESTEROLEMIA, Circulation, 97(8), 1998, pp. 729-735
5-METHYLTETRAHYDROFOLATE, THE ACTIVE FORM OF FOLIC-ACID, RESTORES ENDOTHELIAL FUNCTION IN FAMILIAL HYPERCHOLESTEROLEMIA
Authors: VERHAAR MC WEVER RMF KASTELEIN JJP VANDAM T KOOMANS HA RABELINK TJ
Citation: Mc. Verhaar et al., 5-METHYLTETRAHYDROFOLATE, THE ACTIVE FORM OF FOLIC-ACID, RESTORES ENDOTHELIAL FUNCTION IN FAMILIAL HYPERCHOLESTEROLEMIA, Circulation, 97(3), 1998, pp. 237-241
PREVALENCE OF HEREDITARY HEMOCHROMATOSIS IN PREMATURE ATHEROSCLEROTICVASCULAR-DISEASE
Authors: FRANCO RF ZAGO MA TRIP MD TENCATE H VANDENENDE A PRINS MH KASTELEIN JJP REITSMA PH
Citation: Rf. Franco et al., PREVALENCE OF HEREDITARY HEMOCHROMATOSIS IN PREMATURE ATHEROSCLEROTICVASCULAR-DISEASE, British Journal of Haematology, 102(5), 1998, pp. 1172-1175
FACTOR-11 20210-G-]A POLYMORPHISM IS ASSOCIATED WITH INCREASED RISK FOR ARTERIAL THROMBOTIC DISEASE AND AUGMENTED THROMBIN GENERATION
Authors: FRANCO RF TRIP MD TENCATE H VANDENENDE A PRINS MH KASTELEIN JJP REITSMA PH
Citation: Rf. Franco et al., FACTOR-11 20210-G-]A POLYMORPHISM IS ASSOCIATED WITH INCREASED RISK FOR ARTERIAL THROMBOTIC DISEASE AND AUGMENTED THROMBIN GENERATION, British Journal of Haematology, 102(1), 1998, pp. 147-147
PREVALENCE OF HLA-H MUTATIONS IN PATIENTS WITH PREMATURE ARTERIAL-DISEASE
Authors: FRANCO RF TRIP MD TENCATE H PRINS MH KASTELEIN JJP ZAGO MA REITSMA PH
Citation: Rf. Franco et al., PREVALENCE OF HLA-H MUTATIONS IN PATIENTS WITH PREMATURE ARTERIAL-DISEASE, British Journal of Haematology, 102(1), 1998, pp. 257-257
DIFFERENCES IN THE PHENOTYPE BETWEEN CHILDREN WITH FAMILIAL DEFECTIVEAPOLIPOPROTEIN B-100 AND FAMILIAL HYPERCHOLESTEROLEMIA
Authors: PIMSTONE SN DEFESCHE JC CLEE SM BAKKER HD HAYDEN MR KASTELEIN JJP
Citation: Sn. Pimstone et al., DIFFERENCES IN THE PHENOTYPE BETWEEN CHILDREN WITH FAMILIAL DEFECTIVEAPOLIPOPROTEIN B-100 AND FAMILIAL HYPERCHOLESTEROLEMIA, Arteriosclerosis, thrombosis, and vascular biology, 17(5), 1997, pp. 826-833
PHENOTYPIC VARIATION IN PATIENTS HETEROZYGOUS FOR FAMILIAL DEFECTIVE APOLIPOPROTEIN-B (FDB) IN 3 EUROPEAN COUNTRIES
Authors: HANSEN PS DEFESCHE JC KASTELEIN JJP GERDES LU FRAZA L GERDES C TATO F JENSEN HK JENSEN LG KLAUSEN IC FAERGEMAN O SCHUSTER H
Citation: Ps. Hansen et al., PHENOTYPIC VARIATION IN PATIENTS HETEROZYGOUS FOR FAMILIAL DEFECTIVE APOLIPOPROTEIN-B (FDB) IN 3 EUROPEAN COUNTRIES, Arteriosclerosis, thrombosis, and vascular biology, 17(4), 1997, pp. 741-747
Risultati: 1-25 | 26-50 | 51-75 | 76-100 | >>